These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1463861)

  • 1. Prediction of hormone responsiveness by mammographic parenchymal pattern in advanced primary breast cancer.
    Nielsen NS; Andersen J; Poulsen HS; Mathiessen O
    Breast Cancer Res Treat; 1992; 23(3):219-22. PubMed ID: 1463861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of estrogen receptors with parenchymal pattern at mammography.
    Ciatto S; Cecchini S; Iossa A; Grazzini G; Messeri G; Valenti L; Nunzi G; Bartolucci R; Di Costanzo F
    Radiology; 1989 Mar; 170(3 Pt 1):695-7. PubMed ID: 2916023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation with mammography and estrogen receptors in breast neoplasms].
    Lorenzetti G; De Rubeis GP
    G Ital Oncol; 1990; 10(1-2):41-6. PubMed ID: 2358309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of mammographic parenchymal patterns.
    Roebuck EJ
    Br J Radiol; 1982 Jun; 55(654):387-98. PubMed ID: 7104565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between mammographic parenchymal pattern classification and incidence of breast cancer.
    Threatt B; Norbeck JM; Ullman NS; Kummer R; Roselle P
    Cancer; 1980 May; 45(10):2550-6. PubMed ID: 7378990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer: reliability of mammographic appearance as a predictor of hormone receptor status.
    Ciatto S; Morrone D; Catarzi S; Bonardi R
    Radiology; 1992 Mar; 182(3):805-8. PubMed ID: 1311118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic density and estrogen receptor status of breast cancer.
    Ziv E; Tice J; Smith-Bindman R; Shepherd J; Cummings S; Kerlikowske K
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2090-5. PubMed ID: 15598766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age as a confounding factor in the association of mammographic dysplasia and estrogen receptor concentration in breast cancer.
    Boyd NF; Fishell E; Tonkin K; Mobbs BG
    Breast Cancer Res Treat; 1987 Oct; 10(1):51-4. PubMed ID: 3689983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of background mammographic pattern to hormone dependency in breast cancer.
    Hinton CP; Williams MR; Roebuck EJ; Blamey RW; Glaves J; Nicholson RI; Griffiths K
    Br J Surg; 1984 May; 71(5):357-9. PubMed ID: 6722463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between mammographic features and hormone receptor content in patients with breast cancer.
    Ainge GR; Choplin RH; Bechtold RE; Muss HB; Case LD; Kute TE
    South Med J; 1989 Dec; 82(12):1506-11. PubMed ID: 2688129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer.
    Hinton CP; Roebuck EJ; Williams MR; Blamey RW; Glaves J; Nicholson RI; Griffiths K
    AJR Am J Roentgenol; 1985 Jun; 144(6):1103-7. PubMed ID: 3873788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment.
    Bergkvist L; Tabàr L; Adami HO; Persson I; Bergström R
    Am J Epidemiol; 1989 Sep; 130(3):503-10. PubMed ID: 2763996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.
    Nyante SJ; Sherman ME; Pfeiffer RM; Berrington de Gonzalez A; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Gierach GL
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between the receptor status and the mammographic picture in operable breast cancer].
    Ventrella V; Paradiso A; Farchi G; Tommasi S; Schittulli F; Racanelli A; De Lena M
    Radiol Med; 1990 May; 79(5):483-8. PubMed ID: 2359855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
    Yang WT; Dryden M; Broglio K; Gilcrease M; Dawood S; Dempsey PJ; Valero V; Hortobagyi G; Atchley D; Arun B
    Breast Cancer Res Treat; 2008 Oct; 111(3):405-10. PubMed ID: 18026834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
    Swain SM; Wilson JW; Mamounas EP; Bryant J; Wickerham DL; Fisher B; Paik S; Wolmark N
    J Natl Cancer Inst; 2004 Apr; 96(7):516-23. PubMed ID: 15069113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected prognostic variables for mammographic parenchymal patterns.
    Buchanan JB; Weisberg BF; Sandoz JP; Gray LA; Bland KI
    Cancer; 1981 May; 47(9):2135-7. PubMed ID: 7226106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.